Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cardiovascular effects of metformin and testosterone replacement therapy in older men with hormone-related cancers and cancer-free population

Annals of Epidemiology(2025)10.1016/j.annepidem.2025.12.004Source: DataRank Database

Cardiovascular effects of metformin and testosterone replacement therapy in older men with hormone-related cancers and cancer-free population is a dataset published in Annals of Epidemiology (2025). On theSindex it has a DataRank of 0, placing it in the top 100% of the data-sharing corpus.

Top 100%percentile

0DataRank

Ranks in the top 100% for downstream scientific impact

Data paper Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: hybridTopics (44)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

S. Njoroge,Anirudh S. Babu,Md Ibrahim Tahashilder ORCID,Jesús Gibran Hernández‐Pérez ORCID,Luisa Torres‐Sánchez ORCID

Live enrichment

PubMed:41354168 OpenAlex:https://openalex.org/W4417027469

Cancer Prevention and Research Institute of Texas

Grant: RP210130

National Institute on Aging

Grant: P30 AG059301

National Cancer Institute

Grant: P30CA142543

FWCI

0.00

Citation Percentile

0.2%

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.annepidem.2025.12.004

publisherhttps://doi.org/10.1016/j.annepidem.2025.12.004

publisherhttps://api.elsevier.com/content/article/PII:S1047279725003527?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1047279725003527?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41354168

Fields of Study

Metabolism, Diabetes, and CancerCancer Risks and FactorsCancer, Lipids, and MetabolismHumansMaleMetforminAgedTestosteroneRetrospective StudiesHormone Replacement TherapyCardiovascular DiseasesUnited StatesNeoplasmsAged, 80 and overSEER ProgramHypoglycemic AgentsProportional Hazards ModelsMedicare

MeSH Terms

AgedAged, 80 and overCardiovascular DiseasesMedicareHumansHypoglycemic AgentsMaleMetforminNeoplasmsRetrospective StudiesTestosteroneUnited StatesProportional Hazards ModelsSEER ProgramHormone Replacement Therapy

Keywords

MetforminTestosterone replacementTestosterone (patch)PopulationDiabetes mellitusCancerCardiovascular diseaseColorectal cancerMale breast cancerProstate cancerTestosterone replacement therapy